Literature DB >> 8370379

Quantitative single-photon emission tomography for tumour blood flow measurement in bronchial carcinoma.

N P Rowell1, M A Flower, B Cronin, V R McCready.   

Abstract

A single-photon emission tomography (SPET) technique for the absolute measurement of tumour perfusion is described. Phantom studies have shown that source-background ratios are dependent upon source size and radial position within the phantom. A means of correcting source-background count ratios for these variables has been developed and used to correct tumour-lung ratios obtained in 28 patients with bronchial carcinomas who underwent technetium-99m hexamethylpropyleneamine oxime (99mTc-HMPAO) SPET. On SPET images, the normal lung appears as a relatively homogeneous background. The relationship between 99mTc background concentration (kBq/ml) and counts/pixel was determined from phantom studies and the tumour 99mTc concentration from the background 99mTc concentration and corrected tumour-lung ratio. The total activity of the lipophilic 99mTc-HMPAO species injected was measured. The activity reaching the systemic circulation (Asys) was obtained by subtracting the activity trapped in the pulmonary circulation (obtained from background 99mTc concentration and lung volume). Tumour blood flow may then be calculated from fraction of Asys contained in the tumour provided cardiac output and extraction fraction are known. Blood flow through the central region of tumours ranged from zero to 59.0 (mean 14.1) ml min-1 100 g-1 and through the whole tumour from 0.6 to 68.0 (mean 20.6) ml min-1 100 g-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370379     DOI: 10.1007/bf00176553

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  27 in total

1.  Relationship between size and perfusion rate of transplanted tumors.

Authors:  S CATALAND; C COHEN; L A SAPIRSTEIN
Journal:  J Natl Cancer Inst       Date:  1962-08       Impact factor: 13.506

2.  99mTc-HMPAO as a tumour blood flow agent.

Authors:  P A Hammersley; V R McCready; J W Babich; G Coghlan
Journal:  Eur J Nucl Med       Date:  1987

3.  Improved SPECT quantification using compensation for scattered photons.

Authors:  R J Jaszczak; K L Greer; C E Floyd; C C Harris; R E Coleman
Journal:  J Nucl Med       Date:  1984-08       Impact factor: 10.057

4.  The effects of single dose oral hydralazine on blood flow through human lung tumours.

Authors:  N P Rowell; M A Flower; V R McCready; B Cronin; A Horwich
Journal:  Radiother Oncol       Date:  1990-08       Impact factor: 6.280

5.  Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method.

Authors:  C B Wilson; A A Lammertsma; C G McKenzie; K Sikora; T Jones
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

6.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

7.  Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.

Authors:  D P Nowotnik; L R Canning; S A Cumming; R C Harrison; B Higley; G Nechvatal; R D Pickett; I M Piper; V J Bayne; A M Forster
Journal:  Nucl Med Commun       Date:  1985-09       Impact factor: 1.690

8.  Interstitial fluid pressure in DMBA-induced rat mammary tumours.

Authors:  H Wiig; E Tveit; R Hultborn; R K Reed; L Weiss
Journal:  Scand J Clin Lab Invest       Date:  1982-04       Impact factor: 1.713

9.  Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography.

Authors:  M W Lindegaard; A Skretting; B Hager; K Watne; K F Lindegaard
Journal:  Eur J Nucl Med       Date:  1986

10.  Initial experience with Tc-99m-HM-PAO in the study of brain tumors.

Authors:  J W Babich; F Keeling; M A Flower; L Repetto; A Whitton; S Fielding; A Fullbrook; R J Ott; V R McCready
Journal:  Eur J Nucl Med       Date:  1988
View more
  1 in total

1.  A different approach to the use of unsealed radionuclides for cancer therapy.

Authors:  V R McCready
Journal:  Eur J Nucl Med       Date:  1995-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.